JP2004018436A - Foamable bath medicine - Google Patents
Foamable bath medicine Download PDFInfo
- Publication number
- JP2004018436A JP2004018436A JP2002174138A JP2002174138A JP2004018436A JP 2004018436 A JP2004018436 A JP 2004018436A JP 2002174138 A JP2002174138 A JP 2002174138A JP 2002174138 A JP2002174138 A JP 2002174138A JP 2004018436 A JP2004018436 A JP 2004018436A
- Authority
- JP
- Japan
- Prior art keywords
- mixture containing
- carbonate
- mass
- granules
- organic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 claims abstract description 49
- 230000002378 acidificating effect Effects 0.000 claims abstract description 32
- 239000008187 granular material Substances 0.000 claims abstract description 27
- 150000007524 organic acids Chemical class 0.000 claims abstract description 23
- 238000007906 compression Methods 0.000 claims abstract description 14
- 230000006835 compression Effects 0.000 claims abstract description 14
- 238000000748 compression moulding Methods 0.000 claims abstract description 12
- 239000013040 bath agent Substances 0.000 claims description 39
- 238000005187 foaming Methods 0.000 claims description 33
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 24
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 22
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 20
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 19
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 12
- 239000011780 sodium chloride Substances 0.000 claims description 12
- 239000000654 additive Substances 0.000 claims description 11
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 10
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 10
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 8
- 239000003205 fragrance Substances 0.000 claims description 8
- 230000000996 additive effect Effects 0.000 claims description 6
- 239000002537 cosmetic Substances 0.000 claims description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 5
- 239000004575 stone Substances 0.000 claims description 5
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 4
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- 238000003860 storage Methods 0.000 abstract description 20
- 150000007942 carboxylates Chemical class 0.000 abstract 1
- 238000012856 packing Methods 0.000 abstract 1
- 239000002304 perfume Substances 0.000 abstract 1
- 230000003285 pharmacodynamic effect Effects 0.000 abstract 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 28
- 239000001569 carbon dioxide Substances 0.000 description 14
- 229910002092 carbon dioxide Inorganic materials 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 11
- 239000007789 gas Substances 0.000 description 10
- 235000017550 sodium carbonate Nutrition 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 6
- 229910052782 aluminium Inorganic materials 0.000 description 6
- 229960004106 citric acid Drugs 0.000 description 6
- 235000015165 citric acid Nutrition 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000000465 moulding Methods 0.000 description 4
- 239000001384 succinic acid Substances 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- 238000003287 bathing Methods 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 239000004088 foaming agent Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000004513 sizing Methods 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000003788 bath preparation Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000000395 magnesium oxide Substances 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- 235000012245 magnesium oxide Nutrition 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 235000019719 rose oil Nutrition 0.000 description 2
- 239000010666 rose oil Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 206010016352 Feeling of relaxation Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 241000736892 Thujopsis dolabrata Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- ANBBXQWFNXMHLD-UHFFFAOYSA-N aluminum;sodium;oxygen(2-) Chemical compound [O-2].[O-2].[Na+].[Al+3] ANBBXQWFNXMHLD-UHFFFAOYSA-N 0.000 description 1
- 229940093740 amino acid and derivative Drugs 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 229940051879 analgesics and antipyretics salicylic acid and derivative Drugs 0.000 description 1
- 229960004543 anhydrous citric acid Drugs 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000004083 gastrointestinal agent Substances 0.000 description 1
- 229940127227 gastrointestinal drug Drugs 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 238000012613 in situ experiment Methods 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- -1 jojoba oil Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229910001388 sodium aluminate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 229910000031 sodium sesquicarbonate Inorganic materials 0.000 description 1
- 235000018341 sodium sesquicarbonate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- WCTAGTRAWPDFQO-UHFFFAOYSA-K trisodium;hydrogen carbonate;carbonate Chemical compound [Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O WCTAGTRAWPDFQO-UHFFFAOYSA-K 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Devices For Medical Bathing And Washing (AREA)
Abstract
Description
【0001】
【発明の属する技術分野】
本発明は、発泡性浴用剤に関し、詳しくは、温度や湿度に対して保存安定性が良好である発泡性浴用剤に関する。
【0002】
【従来の技術】
浴用剤は一般に、硫酸ナトリウム、炭酸ナトリウム、炭酸水素ナトリウム等の無機塩類混合物に、香料、色素、植物エキス、有機酸等を配合したもので、浴湯に香りや色調を与えたり、皮膚面に適度な刺激を与えることにより、血液の循環を活発にし、疲労回復、新陳代謝を増進させるものである。そして、これらの浴用剤のうち発泡性浴用剤は、炭酸塩と有機酸とを配合し、浴湯で溶解することにより炭酸ガスを発生し、リラックス感や爽快感を高め、入浴を楽しくする効果がある。
【0003】
従来、このような発泡性浴用剤としては、錠剤型のものが広く汎用されているが、浴湯に入れる前に湿気(水分)が存在すると、炭酸塩と有機酸との中和反応が起こり、炭酸ガスが発生することにより、膨張し、崩れてしまい製品にならない等の問題があった。
【0004】
そこで、このような現象を起こさせないために、結合剤、安定化剤等の圧縮成形用添加剤を配合したり、包装容器の機構や材質に工夫を加える等、種々の防止手段が講じられた上で製品が発売されている。
【0005】
特に圧縮成形添加剤は、錠剤製造にとって必須成分であり、主としてポリエチレングリコール、デンプン、タルク、酸化マグネシウム、ステアリン酸マグネシウム等が使用されている。目的は圧縮成形作業を円滑にすると共に、製剤の成形性を高め、更に保存安定性を良好に保つためである。
【0006】
しかしながら圧縮成形用添加剤には、浴用剤本来の目的である保温効果やリラックス効果は全くない。更に発泡性浴用剤においては、圧縮成形用添加剤が浴湯の透明性を低下させたり、また浮遊物が生じる等、使用に際しては好ましくない技術的問題があった。
【0007】
また錠剤型の発泡性浴用剤は、製造面でも制限がある。すなわち充分な温浴効果を望むためには、1回の入浴には約50gの浴用剤が必要となり、必然的に錠剤の直径は約5cmの大きさになる。また全成分を混合して打錠しなければならないこともあり、通常のかぜ薬や胃腸薬を製造する際に用いる様な小さな打錠機では製造できないため、大型の特殊油圧機を使用しなければならず、誰でも容易には製造できないという大きな問題があった。
【0008】
【発明が解決しようとする課題】
本発明はこのような実情のもとでなされたものであって、温度や湿度に対する保存安定性が良好な発泡性浴用剤を提供することを目的としており、本発明は、大型設備で、大量生産される従来の大型錠剤の発泡性浴用剤とは全く異なるものである。
【0009】
また後述する乾式圧縮造粒機は、移動可能な程コンパクトでありながら、高性能の造粒機であり、小規模生産に適しているが、この機械を使用すればどのような配合処方でも容易に発泡性浴用剤が得られるわけではなく、本発明の目的は、この機械の性能に最適の配合処方を確立することにもある。
【課題を解決するための手段】
【0010】
本発明者等は、乾式圧縮造粒機の性能を熟知した上で鋭意検討し、コハク酸及びクエン酸等の有機酸を含有する酸性混合物並びに炭酸水素ナトリウム及び炭酸ナトリウム等の炭酸塩を含有するアルカリ性混合物を、それぞれ別々に乾式圧縮造粒機にて造粒することにより、酸性造粒物及びアルカリ性造粒物を調製し、その後に同一の容器に充填することにより、温度や湿度に対する保存安定性が良好な発泡性浴用剤が得られることを見出した。更に本発明者等は、油溶性の薬効成分、美容成分、香料等を酸性造粒物に後づけ含浸することで、より安定で製造も容易な発泡性浴用剤が得られることを見出した。
【0011】
また本発明者等は、有機酸を含有する酸性の混合物中の、コハク酸、クエン酸、無水硫酸ナトリウム、及び焼成塩化ナトリウム、並びに炭酸塩を含有するアルカリ性の混合物中の、炭酸水素ナトリウム、炭酸ナトリウム、無水硫酸ナトリウム、及び焼成塩化ナトリウムを、圧縮成形用添加剤を使用せずに特定の比率で配合したときに保存安定性が特に良好な発泡性浴用剤ができることを長期的現場実験を行い確認した。
【0012】
すなわち第1の本発明は、(A)有機酸を含有する酸性の混合物及び(B)炭酸塩を含有するアルカリ性の混合物を、乾式圧縮造粒機により各々顆粒状、フレーク状、又は碎石状に圧縮成形し、且つ得られた2種の造粒物を同一の容器に充填することを特徴とする発泡性浴用剤である。
【0013】
また第2の本発明は、(A)有機酸を含有する酸性の混合物及び(B)炭酸塩を含有するアルカリ性の混合物を、乾式圧縮造粒機により各々顆粒状、フレーク状、又は碎石状に圧縮成形し、更に得られた造粒物の一方又は両方に、香料、美容成分、薬効成分からなる群より選択される油性成分の1種又は2種以上を後づけ含浸させ、且つ得られた造粒物を同一の容器に充填することを特徴とする発泡性浴用剤である。
【0014】
また第3の本発明は、(A)有機酸を含有する酸性の混合物及び(B)炭酸塩を含有するアルカリ性の混合物が、圧縮成形添加剤を含有しないものであることを特徴とする請求項1又は2記載の発泡性浴用剤である。
【0015】
また第4の本発明は、(A)有機酸を含有する酸性の混合物及び(B)炭酸塩を含有するアルカリ性の混合物が、更に無水硫酸塩及び/又は無水塩化ナトリウムを含有するものであることを特徴とする請求項1〜3のいずれか1項に記載の発泡性浴用剤。
【0016】
また第5の本発明は、(A)有機酸を含有する酸性の混合物が、酸性混合物の総量を基準として、コハク酸20〜50質量%、クエン酸20〜50質量%、無水硫酸ナトリウム10〜40質量%、及び焼成塩化ナトリウム10〜40質量%を含有するものであることを特徴とする請求項1〜4のいずれか1項に記載の発泡性浴用剤。
【0017】
また第6の本発明は、(B)炭酸塩を含有するアルカリ性の混合物が、アルカリ性混合物の総量を基準として、炭酸水素ナトリウム20〜60質量%、炭酸ナトリウム10〜40質量%、無水硫酸ナトリウム10〜30質量%、及び焼成塩化ナトリウム10〜30質量%を含有するものであることを特徴とする請求項1〜5のいずれか1項に記載の発泡性浴用剤である。
【0018】
【発明の実施の形態】
以下、構成の詳細を説明する。
【0019】
本発明は酸性造粒物及びアルカリ性造粒物を別々に調製し、その後に両者を混合することを特徴とするため、両者の接触機会が少なく、非常に安定な発泡性入浴剤を得ることができる。
【0020】
酸性造粒物とアルカリ性造粒物とは、質量比2:3〜3:2の範囲内で混合されることが好ましく、pHが中性となるように、1:1の質量比で混合されることが特に好ましい。
【0021】
本発明で用いられる(A)有機酸としては、例えば、クエン酸、リンゴ酸、酒石酸、フマル酸、コハク酸、マロン酸、マレイン酸、ピロリドンカルボン酸、アジピン酸、グルタル酸、安息香酸、サリチル酸、グリコール酸、乳酸、グリセリン酸、ピルビン酸等が挙げられるが、特には、コハク酸及びクエン酸の組み合わせが、炭酸ガス発生量がより多くなり好ましい。
【0022】
本発明で用いられる(A)有機酸の配合量は、それを配合する酸性混合物の総量を基準として、40〜100質量%(以下、単に%と略す)が好ましい。有機酸の配合量が、40%より少ないと炭酸ガス発生量が十分でない場合がある。
また(A)有機酸としてコハク酸及びクエン酸を組み合わせて用いる場合、それを配合する酸性混合物の総量を基準として、コハク酸20〜50%及びクエン酸20〜50%とすることが特に好ましい。
【0023】
本発明で用いられる(B)炭酸塩としては、例えば、炭酸水素ナトリウム、炭酸ナトリウム、セスキ炭酸ナトリウム、炭酸マグネシウム、炭酸カリウム、炭酸水素カリウム、炭酸アンモニウム等が挙げられるが、特には、炭酸水素ナトリウム及び炭酸ナトリウムの組み合わせが、炭酸ガス発生量がより多くなり好ましい。
【0024】
本発明で用いられる(B)炭酸塩の配合量は、それを配合するアルカリ性混合物の総量を基準として、30〜100%が好ましい。炭酸塩の配合量が、30%より少ないと炭酸ガス発生量が十分でない場合がある。
また(B)炭酸塩として炭酸水素ナトリウム及び炭酸ナトリウムを組み合わせて用いる場合、それを配合するアルカリ性混合物の総量を基準として、炭酸水素ナトリウム20〜60%及び炭酸ナトリウム10〜40%とすることが特に好ましい。
【0025】
また本発明においては、更に無水硫酸塩及び無水塩化ナトリウムを組み合わせて配合することにより、堅牢な多孔性の造粒物を得ることができる。
【0026】
本発明で用いられる無水硫酸塩は、通常化粧料に用いられるものでよいが、好ましくは、無水硫酸ナトリウムであり、特に100〜140メッシュの無水硫酸ナトリウムが、製造の際に便利であり、温浴効果を十分に高めるので好ましい。
【0027】
本発明で用いられる無水塩化ナトリウムは、通常化粧料に用いられるものでよいが、保存安定性の面から、焼成塩化ナトリウムが好ましい。焼成塩化ナトリウムは、塩化ナトリウムを140℃で90分焼いた後、粉碎し、140メッシュが90%以上になるようにふるいを通して得られるものがより好ましい。
【0028】
本発明で用いられる乾式圧縮造粒機とは、回転する2個のロール間で、化学薬品や食品等の原料を圧縮し、成形する小型の可搬式機械である。その代表的なものとしてコンパクティングマシン(例えば、ターボ工業社製のWP230×120)が挙げられる。
【0029】
コンパクティングマシンは、たがいに喰い込み、同速で回転する2個のロール間で粉末原料を圧縮し、成形するものであり、ロール外周面にポケットを刻まない平滑ロール、又は波形ロール、模様を刻んだロール等を使用することにより、板状(フレーク)に成形し、次にこのフレークを架碎整粒機で解碎し、更にふるいにかけて、所望の大きさのフレーク状、顆粒状、又は碎石状の造粒物を得ることができる。特に粒径が4〜6mmの顆粒状の造粒物が好ましい。また成形圧力を0.01〜5t/cm2の範囲内に調整することにより、特に優れた保存安定性を有する発泡性浴用剤を得ることができる。
【0030】
本発明の(A)有機酸を含有する酸性の混合物及び(B)炭酸塩を含有するアルカリ性の混合物は、前記の乾式圧縮造粒機により、各々顆粒状、フレーク状、又は碎石状に圧縮成形され、酸性造粒物及びアルカリ性造粒物となるが、(A)有機酸を含有する酸性の混合物及び(B)炭酸塩を含有するアルカリ性の混合物は、圧縮成形用添加剤を含有しないものであることが好ましい。
【0031】
圧縮成形用添加剤(結合剤、滑沢剤、安定化剤)は、圧縮成形作業を円滑にすると共に、製剤の成形性を高め、更に造粒物の保存安定性を良好に保つために配合されるものであるが、本発明は、カゼイン、カルボキシメチルセルロースナトリウム、水溶性ゼラチン、ペクチン、デンプン、メチルセルロース、エチルセルロース、アルギン酸ナトリウム、ポリビニルアルコール、ポリビニルピロリドン、ポリビニルメチルエーテル、ポリエチレングリコール、カラヤゴム、ローカストビーンガム、トラガントガム、カラギーナン、カルボキシビニルポリマー、アカシヤガム、カンテン、デキストリン、サイクロデキストリン、ソルビトール、還元麦芽糖水飴等の結合剤、ステアリン酸マグネシウム、ステアリン酸カルシウム、タルク等の滑沢剤、酸化マグネシウム、アルミン酸ソーダ等の安定化剤を全く使用しない。
【0032】
また本発明の酸性造粒物及びアルカリ性造粒物は、共に極めて堅牢な多孔性であり、香料、美容成分、薬効成分等の油性成分を後づけ含浸することができ、保存に際してはより安定であり過剰な防湿対策は不用である。特に酸性造粒物に含浸させる方が、保存安定性の面でより好ましい。
【0033】
後づけ含浸の方法としては、酸性造粒物又はアルカリ性造粒物を調製後、一定量の油性成分を噴霧混合し、造粒物の表面に油性成分を付着させる。
【0034】
本発明で用いられる香料としては、ラベンダー油、ジャスミン油、ローズ油、レモン油、オレンジ油、ハッカ油、タイム油、ショウブ油、ヒバ油、ヒノキ油、バラ油、ユーカリ油、カンファー、ペパーミント油、スペアミント油、ゲラニオール、シトロネロール等の天然又は合成香料が挙げられる。
【0035】
本発明で用いられる美容成分としては、ヒマシ油、オリーブ油、グレープシード油、椿油、ホホバ油、アボガド油、大豆油、アーモンド油、ヤシ油、パーム油、米糠油、米胚芽油、ゴマ油、タートル油、ミンク油等の油脂類、コラーゲン、ケラチン等のタンパク質及びその誘導体、グルタミン酸ナトリウム、トリメチルグリシン等のアミノ酸及びその誘導体、スクワラン等が挙げられる。
【0036】
また本発明で用いられる薬効成分としては、グリチルリチン酸、グリチルレチン酸、サリチル酸及びそれらの誘導体、アラントイン、ヒノキチオール、ビタミンE等が挙げられる。
【0037】
本発明の発泡性浴用剤は、保存安定性が極めて良好なため、通常用いられる分包や樹脂製のボトルをはじめ、様々な形状や材質の容器に、過剰な防湿対策をしなくても製品化ができ、そのためコストも安くなる。
【0038】
本発明は、発泡性浴用剤以外にも、発泡により有効成分を水中に溶解や分散させたい用途、例えば洗顔剤、手指・足等の部分浴剤、含嗽剤、洗浄剤、消臭・芳香剤等の用途に広く応用できる。
【実施例】
【0039】
以下、実施例を挙げ本発明を説明するが、本発明はこれら実施例により限定されるものではない。また、本実施例中で用いた保存安定性の試験方法、及び製造方法を以下に示す。尚、表中の数値は配合量(質量%)を示す。
【0040】
[保存安定性の試験方法]
実施例及び比較例の発泡性浴用剤50gをアルミ分包に密閉し、下記の条件で保存した後、新たに製造したものと外観(発泡性浴用剤の崩落の有無、アルミ分包の膨張の有無)、及び炭酸ガス発生量を比較した。
【0041】
<保存条件>
温度55℃、湿度80%の恒温器中に 6ヶ月間
温度45℃、湿度80%の恒温器中に12ヶ月間
平均温度25℃の室内に18ヶ月間
【0042】
<炭酸ガス発生量の測定方法>
300mLの大型シリンジの底部に、碎いた発泡性浴用剤2gを入れ、別の小型シリンジに10mLの温水を入れて連結し、大型シリンジ中に温水を注入して炭酸ガスを発生させる。発生した炭酸ガスは自然にピストンを押し上げるので、試料が完全に溶解した時の目盛を読み取って炭酸ガス発生量とした。
【0043】
実施例1
表1に示す処方の組成物を、下記の製造方法により調製し、前記保存安定性試験を行った。
【0044】
【表1】
【0045】
[製造方法]
表1に示す処方の組成物(酸性造粒物、アルカリ性造粒物の各々)を、成形用添加剤を使用することなく、ターボ工業社製のWP230×120を用いて、板状の酸性圧縮成形物及びアルカリ性圧縮成形物を調製した。次に各々を架碎整粒機を用いて、粒径4〜6mm、見かけ比重1.0の顆粒状〜碎石状の酸性造粒物及びアルカリ性造粒物を調製した。尚、香料は顆粒状〜碎石状の酸性造粒物に噴霧含浸させた。次に得られた酸性造粒物及びアルカリ性造粒物を、V型混合機を用いて、質量比1:1で混合したものを、アルミ分包に50g充填密封して実施例1の発泡性浴用剤とした。
【0046】
比較例1
表2に示す処方の組成物を、下記の製造方法により調製し、前記保存安定性試験を行った。
【0047】
【表2】
【0048】
[製造方法]
表2に示す処方の組成物を、成形用添加剤を使用することなく、ターボ工業社製のWP230×120を用いて、板状の圧縮成形物を調製した。次に架碎整粒機を用いて、粒径4〜6mm、見かけ比重1.0の顆粒状〜碎石状造粒物を調製した。尚、香料は顆粒状〜碎石状の造粒物に噴霧含浸させたものを、アルミ分包に50g充填密封して比較例1の発泡性浴用剤とした。
【0049】
[保存安定性の試験結果]
実施例1の発泡性浴用剤は上記の保存条件に対して安定であり、外観の変化(発泡性浴用剤の崩落、アルミ分包の膨張)は認められず、更に炭酸ガス発生量も、2gの発泡性浴用剤から230ccを測定し、新たに製造したものと同一であった。一方、比較例1の発泡性浴用剤は、アルミ分包の膨張が認められた。
【0050】
[浴用効果]
実施例1の発泡性浴用剤約50gを、約180Lの浴湯中に投入すると、微細な炭酸ガスの泡が持続的に発生した。
また実施例1の発泡性浴用剤5〜10gを、約10Lの湯を入れた容器の中に投入すると、手や足を浸しているうちに全身が暖まり、浴後の爽快感を味わうことができた。
【0051】
【発明の効果】
以上記載したように、本発明は、温度や湿度に対する保存安定性が良好な発泡性浴用剤を容易に得ることができる。[0001]
TECHNICAL FIELD OF THE INVENTION
The present invention relates to an effervescent bath agent, and more particularly, to an effervescent bath agent having good storage stability against temperature and humidity.
[0002]
[Prior art]
A bath agent is generally a mixture of inorganic salts such as sodium sulfate, sodium carbonate, sodium hydrogen carbonate, etc., mixed with a fragrance, a pigment, a plant extract, an organic acid, etc. By giving an appropriate stimulus, blood circulation is activated, and fatigue recovery and metabolism are promoted. And among these bath agents, the foaming bath agent mixes carbonates and organic acids, and dissolves in the bath water to generate carbon dioxide gas, enhance the feeling of relaxation and exhilaration, and make bathing fun. There is.
[0003]
Conventionally, tablet-type foaming agents have been widely used as such a foaming bath agent. However, if moisture (moisture) is present before the bathing agent is added, a neutralization reaction between the carbonate and the organic acid occurs. In addition, there is a problem that the carbon dioxide gas is expanded and collapsed due to the generation of carbon dioxide gas to prevent the product from being produced.
[0004]
Therefore, in order to prevent such a phenomenon from occurring, various preventive measures have been taken such as blending additives for compression molding such as a binder and a stabilizer, and devising the mechanism and material of the packaging container. The product has been launched above.
[0005]
In particular, compression molding additives are essential components for tablet production, and mainly polyethylene glycol, starch, talc, magnesium oxide, magnesium stearate and the like are used. The purpose is to smooth the compression molding operation, enhance the moldability of the preparation, and keep the storage stability favorable.
[0006]
However, the additives for compression molding do not have any heat retaining effect or relaxing effect which is the original purpose of the bath agent. Further, in the foaming bath agent, there are undesired technical problems in use, such as the compression molding additive lowering the transparency of the bath water and generating a floating substance.
[0007]
In addition, tablet-type foaming bath agents are limited in terms of production. That is, in order to obtain a sufficient warm bath effect, about 50 g of a bath agent is required for one bath, and the diameter of the tablet is inevitably about 5 cm. In addition, since all components must be mixed and tableted, it cannot be manufactured with a small tableting machine used for manufacturing ordinary cold and gastrointestinal drugs, so a large special hydraulic machine must be used. There was a major problem that no one could easily manufacture.
[0008]
[Problems to be solved by the invention]
The present invention has been made under such circumstances, and an object of the present invention is to provide a foaming bath agent having good storage stability with respect to temperature and humidity. It is completely different from the conventional effervescent bath preparation for large tablets.
[0009]
In addition, the dry compression granulator described below is a compact, high-performance granulator that can be moved, and is suitable for small-scale production. However, it is also an object of the present invention to establish an optimal formulation for the performance of this machine.
[Means for Solving the Problems]
[0010]
The present inventors have thoroughly studied the performance of a dry compression granulator and have studied them thoroughly, and contain an acidic mixture containing an organic acid such as succinic acid and citric acid and a carbonate such as sodium hydrogen carbonate and sodium carbonate. The alkaline mixture is separately granulated by a dry compression granulator to prepare acidic granules and alkaline granules, and then filled in the same container to ensure storage stability against temperature and humidity. It has been found that a foaming bath agent having good properties can be obtained. Furthermore, the present inventors have found that a foaming bath agent that is more stable and easy to produce can be obtained by post-impregnating an acidic granulated product with an oil-soluble medicinal component, cosmetic component, fragrance and the like.
[0011]
The present inventors have also found that sodium bicarbonate, carbonic acid in an alkaline mixture containing succinic acid, citric acid, anhydrous sodium sulfate, and calcined sodium chloride, and carbonate in an acidic mixture containing an organic acid. Long-term in-situ experiments were conducted to show that foaming bath agents with particularly good storage stability can be obtained when sodium, anhydrous sodium sulfate, and calcined sodium chloride are blended in a specific ratio without using compression molding additives. confirmed.
[0012]
That is, the first aspect of the present invention provides a method in which an acidic mixture containing (A) an organic acid and an alkaline mixture containing (B) a carbonate are granulated, flaked, or crushed, respectively, by a dry compression granulator. The foaming bath agent is characterized by being compression-molded and filled in the same container with the two obtained granules.
[0013]
Further, the second present invention provides a method in which an acidic mixture containing (A) an organic acid and an alkaline mixture containing (B) a carbonate are granulated, flaked or crushed by a dry compression granulator. Compression molded into one or more of the obtained granules, and subsequently impregnated one or more of oily components selected from the group consisting of fragrances, cosmetic ingredients, and medicinal ingredients into one or both of the obtained granules; The foaming bath agent is characterized by filling the same granules in the same container.
[0014]
According to a third aspect of the present invention, the acidic mixture containing (A) an organic acid and the alkaline mixture containing (B) a carbonate do not contain a compression molding additive. 3. The foaming bath agent according to 1 or 2.
[0015]
According to a fourth aspect of the present invention, (A) the acidic mixture containing an organic acid and (B) the alkaline mixture containing a carbonate further contain anhydrous sulfate and / or anhydrous sodium chloride. The foaming bath agent according to any one of claims 1 to 3, characterized in that:
[0016]
Further, the fifth invention is characterized in that (A) the acidic mixture containing an organic acid is composed of 20 to 50% by mass of succinic acid, 20 to 50% by mass of citric acid, 10 to 50% by mass of anhydrous sodium sulfate based on the total amount of the acidic mixture. The foaming agent for foaming bath according to any one of claims 1 to 4, comprising 40% by mass and 10 to 40% by mass of calcined sodium chloride.
[0017]
In a sixth aspect of the present invention, the alkaline mixture containing (B) carbonate is 20 to 60% by mass of sodium hydrogen carbonate, 10 to 40% by mass of sodium carbonate, 10% by mass of anhydrous sodium sulfate, based on the total amount of the alkaline mixture. The foaming bath agent according to any one of claims 1 to 5, wherein the foaming bath agent contains 1 to 30% by mass and 10 to 30% by mass of calcined sodium chloride.
[0018]
BEST MODE FOR CARRYING OUT THE INVENTION
Hereinafter, the configuration will be described in detail.
[0019]
The present invention is characterized by separately preparing an acidic granulated product and an alkaline granulated product, and then mixing both, so that there is little chance of contact between the two, and a very stable foaming bath agent can be obtained. it can.
[0020]
The acidic granules and the alkaline granules are preferably mixed in a mass ratio of 2: 3 to 3: 2, and mixed at a mass ratio of 1: 1 so that the pH becomes neutral. Is particularly preferred.
[0021]
Examples of the (A) organic acid used in the present invention include citric acid, malic acid, tartaric acid, fumaric acid, succinic acid, malonic acid, maleic acid, pyrrolidone carboxylic acid, adipic acid, glutaric acid, benzoic acid, salicylic acid, Glycolic acid, lactic acid, glyceric acid, pyruvic acid and the like can be mentioned. In particular, a combination of succinic acid and citric acid is preferable because the amount of carbon dioxide gas generated is larger.
[0022]
The amount of the organic acid (A) used in the present invention is preferably 40 to 100% by mass (hereinafter simply abbreviated to%), based on the total amount of the acidic mixture in which the organic acid is incorporated. If the amount of the organic acid is less than 40%, the amount of carbon dioxide generated may not be sufficient.
Further, when succinic acid and citric acid are used in combination as the organic acid (A), it is particularly preferable that succinic acid is 20 to 50% and citric acid is 20 to 50% based on the total amount of the acidic mixture in which it is blended.
[0023]
Examples of the (B) carbonate used in the present invention include sodium bicarbonate, sodium carbonate, sodium sesquicarbonate, magnesium carbonate, potassium carbonate, potassium bicarbonate, and ammonium carbonate. And sodium carbonate are preferable because the amount of carbon dioxide gas generated is larger.
[0024]
The amount of the carbonate (B) used in the present invention is preferably 30 to 100%, based on the total amount of the alkaline mixture in which the carbonate is mixed. If the amount of the carbonate is less than 30%, the amount of carbon dioxide generated may not be sufficient.
In the case where sodium carbonate and sodium carbonate are used in combination as (B) carbonate, it is particularly preferable to set sodium hydrogencarbonate to 20 to 60% and sodium carbonate to 10 to 40% based on the total amount of the alkaline mixture in which it is blended. preferable.
[0025]
Further, in the present invention, a robust porous granulated product can be obtained by further combining and combining anhydrous sulfate and anhydrous sodium chloride.
[0026]
The anhydrous sulfate used in the present invention may be one usually used in cosmetics, but is preferably anhydrous sodium sulfate, particularly anhydrous sodium sulfate of 100 to 140 mesh is convenient at the time of production, It is preferable because the effect is sufficiently enhanced.
[0027]
The anhydrous sodium chloride used in the present invention may be one usually used for cosmetics, but from the viewpoint of storage stability, calcined sodium chloride is preferred. The calcined sodium chloride is more preferably one obtained by baking sodium chloride at 140 ° C. for 90 minutes, pulverizing, and passing through a sieve so that the 140 mesh becomes 90% or more.
[0028]
The dry compression granulator used in the present invention is a small portable machine that compresses and forms raw materials such as chemicals and foods between two rotating rolls. A typical example thereof is a compacting machine (for example, WP230 × 120 manufactured by Turbo Kogyo KK).
[0029]
The compacting machine compresses the powder raw material between two rolls rotating at the same speed by pressing into each other, and molding, and forms a smooth roll, a corrugated roll, or a pattern without engraving pockets on the outer peripheral surface of the roll. By using a chopped roll or the like, it is formed into a plate shape (flakes), and then the flakes are crushed by a crushing and sizing machine and further sieved to obtain flakes, granules, or Crushed granules can be obtained. Particularly, a granulated product having a particle size of 4 to 6 mm is preferable. By adjusting the molding pressure within the range of 0.01 to 5 t / cm 2 , a foaming bath agent having particularly excellent storage stability can be obtained.
[0030]
The (A) acidic mixture containing an organic acid and (B) an alkaline mixture containing a carbonate are compressed into granules, flakes, or crushed stones by the dry compression granulator described above. It is formed into acidic granules and alkaline granules, but (A) an acidic mixture containing an organic acid and (B) an alkaline mixture containing a carbonate do not contain a compression molding additive. It is preferable that
[0031]
Additives for compression molding (binders, lubricants, stabilizers) are added to smooth the compression molding operation, enhance the moldability of the formulation, and maintain good storage stability of the granules. The present invention relates to casein, sodium carboxymethylcellulose, water-soluble gelatin, pectin, starch, methylcellulose, ethylcellulose, sodium alginate, polyvinyl alcohol, polyvinylpyrrolidone, polyvinylmethylether, polyethylene glycol, karaya gum, locust bean gum. Binders, such as tragacanth gum, carrageenan, carboxyvinyl polymer, acacia gum, agar, dextrin, cyclodextrin, sorbitol, reduced maltose syrup, lubricating agents such as magnesium stearate, calcium stearate, and talc Magnesium oxide, not used at all stabilizers such as sodium aluminate.
[0032]
The acidic granules and the alkaline granules of the present invention are both extremely robust and porous, and can be impregnated with oily components such as fragrances, cosmetic ingredients, and medicinal ingredients, and are more stable during storage. There is no need for excessive moisture protection. In particular, it is more preferable to impregnate the acidic granules in terms of storage stability.
[0033]
As a method of post-impregnation, after preparing an acidic granulated product or an alkaline granulated product, a fixed amount of an oily component is spray-mixed to adhere the oily component to the surface of the granulated product.
[0034]
As the fragrance used in the present invention, lavender oil, jasmine oil, rose oil, lemon oil, orange oil, peppermint oil, thyme oil, shobu oil, hiba oil, hinoki oil, rose oil, eucalyptus oil, camphor, peppermint oil, Natural or synthetic flavors such as spearmint oil, geraniol, citronellol and the like can be mentioned.
[0035]
Cosmetic components used in the present invention include castor oil, olive oil, grape seed oil, camellia oil, jojoba oil, avocado oil, soybean oil, almond oil, coconut oil, palm oil, rice bran oil, rice germ oil, sesame oil, turtle oil Oils and fats such as mink oil; proteins and derivatives thereof such as collagen and keratin; amino acids and derivatives thereof such as sodium glutamate and trimethylglycine; and squalane.
[0036]
The medicinal ingredients used in the present invention include glycyrrhizic acid, glycyrrhetinic acid, salicylic acid and derivatives thereof, allantoin, hinokitiol, vitamin E and the like.
[0037]
Since the foaming bath agent of the present invention has extremely good storage stability, it can be used in containers of various shapes and materials, including commonly used sachets and resin bottles, without using excessive moisture-proof measures. The cost can be reduced.
[0038]
The present invention can be used for dissolving or dispersing the active ingredient in water by foaming, in addition to the foaming bath agent, for example, a face wash, a partial bath for fingers and feet, a gargle, a cleaning agent, a deodorant and a fragrance. Widely applicable to applications such as
【Example】
[0039]
Hereinafter, the present invention will be described with reference to examples, but the present invention is not limited to these examples. The test method of storage stability and the production method used in this example are shown below. In addition, the numerical value in a table | surface shows a compounding quantity (mass%).
[0040]
[Test method for storage stability]
After 50 g of the foaming bath agent of the examples and comparative examples were sealed in an aluminum package and stored under the following conditions, the newly manufactured product and the appearance (whether or not the foaming agent collapsed, the expansion of the aluminum package) Presence / absence) and the amount of generated carbon dioxide.
[0041]
<Storage conditions>
18 months in a room with an average temperature of 25 ° C for 12 months in a thermostat with a temperature of 45 ° C and 80% humidity for 6 months in a thermostat at 55 ° C and 80% humidity
<Method of measuring the amount of generated carbon dioxide>
At the bottom of a large 300 mL syringe, 2 g of the crushed foaming bath agent is put, and 10 mL of hot water is put into another small syringe and connected, and hot water is injected into the large syringe to generate carbon dioxide gas. Since the generated carbon dioxide gas naturally pushes up the piston, the scale when the sample was completely dissolved was read to determine the amount of generated carbon dioxide gas.
[0043]
Example 1
Compositions having the formulations shown in Table 1 were prepared by the following production methods and subjected to the storage stability test.
[0044]
[Table 1]
[0045]
[Production method]
Each of the compositions (each of the acidic granulated product and the alkaline granulated product) having the formulation shown in Table 1 was subjected to plate-shaped acidic compression using WP230 × 120 manufactured by Turbo Kogyo without using a molding additive. A molded article and an alkaline compression molded article were prepared. Next, using a crushing and sizing machine, a granular to crushed acidic granulated product and an alkaline granulated product having a particle size of 4 to 6 mm and an apparent specific gravity of 1.0 were prepared. The flavor was spray-impregnated into granular to crushed acidic granules. Next, the obtained acidic granulated product and alkaline granulated product were mixed at a mass ratio of 1: 1 using a V-type mixer, and 50 g was sealed in an aluminum package and sealed. It was used as a bath agent.
[0046]
Comparative Example 1
Compositions having the formulations shown in Table 2 were prepared by the following production methods and subjected to the storage stability test.
[0047]
[Table 2]
[0048]
[Production method]
A plate-shaped compression molded product was prepared from the composition having the formulation shown in Table 2 using WP230 × 120 manufactured by Turbo Kogyo without using a molding additive. Next, using a crushing and sizing machine, granular to crushed stone granules having a particle size of 4 to 6 mm and an apparent specific gravity of 1.0 were prepared. The fragrance was spray impregnated into granules from granules to crushed stones, and 50 g was filled in an aluminum package and sealed to obtain a foaming bath agent of Comparative Example 1.
[0049]
[Test results of storage stability]
The foaming bath agent of Example 1 was stable under the above storage conditions, no change in appearance (collapse of the foaming bath agent, expansion of the aluminum package) was observed, and the amount of carbon dioxide gas generated was 2 g. Of the foaming bath agent was measured, and the result was the same as that of a freshly manufactured bath agent. On the other hand, in the foaming bath agent of Comparative Example 1, expansion of the aluminum package was observed.
[0050]
[Bath effect]
When about 50 g of the foaming bath agent of Example 1 was introduced into about 180 L of bath water, fine carbon dioxide gas bubbles were continuously generated.
Also, when 5 to 10 g of the foaming bath preparation of Example 1 is put into a container containing about 10 L of hot water, the whole body warms while the hands and feet are immersed, and the refreshing feeling after bathing can be enjoyed. Was.
[0051]
【The invention's effect】
As described above, according to the present invention, a foaming bath agent having good storage stability against temperature and humidity can be easily obtained.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002174138A JP2004018436A (en) | 2002-06-14 | 2002-06-14 | Foamable bath medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002174138A JP2004018436A (en) | 2002-06-14 | 2002-06-14 | Foamable bath medicine |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2004018436A true JP2004018436A (en) | 2004-01-22 |
Family
ID=31173188
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002174138A Pending JP2004018436A (en) | 2002-06-14 | 2002-06-14 | Foamable bath medicine |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2004018436A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005314233A (en) * | 2004-04-27 | 2005-11-10 | Kao Corp | Two-agent type bathing agent |
JP2010037264A (en) * | 2008-08-05 | 2010-02-18 | Tanpei Seiyaku Kk | Effervescent bath agent |
JP2011016749A (en) * | 2009-07-08 | 2011-01-27 | Kao Corp | Granular effervescent bath salt |
JP2011021005A (en) * | 2009-06-16 | 2011-02-03 | Kao Corp | Bubbling powder bathing agent composition |
JP2014097961A (en) * | 2012-11-15 | 2014-05-29 | Kao Corp | Powdery bath agent composition |
JP2015120648A (en) * | 2013-12-20 | 2015-07-02 | 花王株式会社 | Method of producing foamable composition |
JP2017197582A (en) * | 2017-08-09 | 2017-11-02 | 花王株式会社 | Powdery bath agent composition |
-
2002
- 2002-06-14 JP JP2002174138A patent/JP2004018436A/en active Pending
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005314233A (en) * | 2004-04-27 | 2005-11-10 | Kao Corp | Two-agent type bathing agent |
JP4504729B2 (en) * | 2004-04-27 | 2010-07-14 | 花王株式会社 | Two-component bath agent |
JP2010037264A (en) * | 2008-08-05 | 2010-02-18 | Tanpei Seiyaku Kk | Effervescent bath agent |
JP2011021005A (en) * | 2009-06-16 | 2011-02-03 | Kao Corp | Bubbling powder bathing agent composition |
JP2011016749A (en) * | 2009-07-08 | 2011-01-27 | Kao Corp | Granular effervescent bath salt |
JP2014097961A (en) * | 2012-11-15 | 2014-05-29 | Kao Corp | Powdery bath agent composition |
JP2015120648A (en) * | 2013-12-20 | 2015-07-02 | 花王株式会社 | Method of producing foamable composition |
JP2017197582A (en) * | 2017-08-09 | 2017-11-02 | 花王株式会社 | Powdery bath agent composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH11246390A (en) | Bath preparation having mineral spring effect particularly in the form of foaming tablet and its production and usage | |
CN107920962A (en) | Rapidly disintegrating granular pellet composition for hair cleansing | |
JP2016008181A (en) | Kit for skin external preparation | |
JP5692618B1 (en) | Skin preparation kit | |
JP2004018436A (en) | Foamable bath medicine | |
JP2001139454A (en) | Bubbling bath agent and method for producing the same | |
JP2002275051A (en) | Solid cosmetic | |
JP5531177B1 (en) | Skin preparation kit | |
JP6108363B2 (en) | Skin preparation kit | |
JP6142343B2 (en) | One-part skin external preparation | |
JP2021187784A (en) | Granule-blended foamable tablet | |
JP7300195B2 (en) | Effervescent topical skin preparation | |
JP6355283B2 (en) | Effervescent skin external preparation | |
JPS58192814A (en) | Cosmetic | |
JP6648230B2 (en) | Skin preparation kit | |
JP2022095943A (en) | Foamable skin external preparation kit | |
JP2004059606A (en) | Press-molded solid matter | |
JP5888566B2 (en) | Skin preparation kit | |
JP6851646B2 (en) | Kit for external preparations for skin | |
JP7656352B2 (en) | Foaming skin care product | |
JP6628197B2 (en) | Skin preparation kit | |
JP4348208B2 (en) | Compression mold bath agent | |
JP3936716B2 (en) | Solid cosmetics | |
JP2006219417A (en) | Solid foamable bathing agent composition | |
JP2008162923A (en) | Method for producing bathing agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040804 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20051003 |
|
A131 | Notification of reasons for refusal |
Effective date: 20061121 Free format text: JAPANESE INTERMEDIATE CODE: A131 |
|
A02 | Decision of refusal |
Effective date: 20070320 Free format text: JAPANESE INTERMEDIATE CODE: A02 |